Fundings & Collaborations
Discover a comprehensive overview of funding initiatives and collaborations participated by OrganoVIR Labs.
- H2020-NMBP-TR-IND-2020-twostage 953201: GUTVIBRATIONS: Gut Virus Brain Axis Technology in Organoid Science (2020)
*coordinator
GUTVIBRATIONS is a multidisciplinary and international consortium that will develop a multi-organ system that will simulate the human body and provides an animal-free solution for modelling human diseases and pre-clinical drug development.
Grant amount: €6,000,000
- H2020-MSCA-ITN-2018 Marie Curie Innovative Training Networks programme: OrganoVIR: Organoids for Virus Research (2018)
*coordinator
Funded by the Marie Skłodowska-Curie Actions programme, the OrganoVIR project will develop a research training network to study human viral infection in 3D cell cultures (organoids). The goal is to establish human organoids as superior models for viral pathogenesis studies and antiviral testing, replacing animal models. This programme will educate young researchers on the scientific and technical aspects of organoids for virus research and also on the financial, ethical, commercial and legal aspects of organoid technology.
Grant Amount: €4,000,000
*Principal Investigator
Together with nine international partners, OrganoVIR Labs will combine novel brain-on-chip technology with super-resolution microscopy to develop innovative solutions for dengue prevention and treatment.
Grant Amount: €8,000,000
- HORIZON-HLTH-2023-DISEASE-03: COMMUTE: COMORBIDITY MECHANISMS UTILIZED IN HEALTHCARE (2023)
*Principal Investigator
Together with ten other esteemed European partners, OrganoVIR Labs will contribute to an EU-funded project that aims to unravel the underlying mechanisms linking COVID-19 infections with neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Grant Amount: €7,300,000
- Zeldzame Ziekte Fonds (ZZF): Multi-omics in Neurological and Neurocognitive functioning in HIV infected children; NOVICE study, a case –control cohort (2024)
*Applicant
Grant Amount: €106,000
- ADVOCATE: Advanced complexity in human derived organoid models for virology; PPP Allowance 2022 TKI Health-Holland (2023)
*Principal Investigator
Grant Amount: €196,000
- Goed Gebruik Geneesmiddelen Open Ronde 10-UA. Study to optimize Antiretroviral regimes in HIV infected women who want to breastfeed (PANNA-B) (2021)
*Principal Investigator
Grant Amount: €330,000
- TPI-PPP Allowance of TKI-LSH: Focus-on-Virus: Picornavirus and HIV infection using a complex gut-brain model (2020)
*Coordinator
Grant Amount: €1,300,000
- TPI-PPP Allowance of TKI-LSH: Focus-on-Virus: Picornavirus and HIV infection using a complex gut-brain model (2020)
*Coordinator
Grant Amount: €1,300,000
- Van Herk Foundation: CMV Brain Organoid Studies (2020)
*Principal Investigator
Grant Amount: €250,000
- ZONMW Meer Kennis met Minder Dieren, Module Societal Partners: Virus research in human models: let’s show some guts (2016)
*Principal Investigator
- Stichting Mitialto: NOVICE study (2016)
- Dr. CJ Vaillantfonds: NOVICE and NOVICE 2 study (2016, 2018)
- AIDS Fonds: Neurological and neurocognitive impairment of perinatally hiv-infected children, NOVICE study (2015, 2016)
- AIDS Fonds: Improved therapy adherence for hiv-infected adolescents using a connected wearable within a cloud-based medication management platform (2018)
- Emma foundation: COVID KIDS Study (2020), Neurological and Neurocognitive functioning in HIV infected children; NOVICE study, a case –control study (2011), Pediatric causes of central nervous system infection (2012), Medication adherence in chronically ill adolescents and young adults (BRAVU study) (2017)
The COVID-Kids study investigates how many children carry antibodies against the virus and how the immune response to the virus works. The more people have antibodies, the more difficult it is for the virus to spread further. The financing of the COVID-Kids study is made possible by a contribution from the Contribute Foundation to Stichting Steun Emma Kinderziekenhuis.